EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis

Haris Imsirovic, Gisela Macphail, Brian Conway, Chris Fraser, Sergio Borgia, Daniel Smyth, Alexander Wong, Marie-Louise Vachon, Duncan Webster, Hongqun Liu, Jordan Feld, Sam Lee und 2 weitere

Journal of Viral Hepatitis · 2024

DOI: 10.1111/jvh.13995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Haris Imsirovic und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ottawa Hospital Research Institute, Ottawa, Canada. Hauptthemen laut MEDLINE: Antiviral Agents, Hepacivirus, Genotype, Sustained Virologic Response. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of mixed hepatitis C virus (HCV) genotype infection in a representative Canadian HCV cohort is reported and virological response with direct acting antiviral (DAA) treatment was evaluated. 3272 HCV‐positive participants were enrolled, of which 2945 (90.0%) initiated DAA therapy. 0.8% were identified with mixed genotype infection. Overall sustained virological response (SVR) was 99.1% and did not differ based on mixed genotype status. Any historical disadvantage to achieving cure with HCV treatment in mixed genotype infection has been overcome by current DAA regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepacivirusGenotypeSustained Virologic ResponseHepatitis C, ChronicHumansMaleFemaleMiddle AgedCanadaTreatment OutcomeAdultAgedCoinfectionPrevalenceCohort Studies

Stichwörter der Autor:innen

direct acting antiviralshepatitis Cmixed genotypesoutcomes

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Ottawa Hospital Research Institute, Ottawa, Canada.
  • University of Calgary, Calgary, Canada.
  • Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada.
  • University of Victoria, Victoria, Canada.
  • William Osler Health System, Division of Infectious Diseases, Brampton, Canada.
  • McMaster University, Division of Infectious Diseases, Hamilton, Canada.

Zitieren

APA

Imsirovic, H., Macphail, G., Conway, B., Fraser, C., Borgia, S., Smyth, D., Wong, A., Vachon, M. L., Webster, D., Liu, H., Feld, J., Lee, S., Cooper, C., & Canadian Network Undertaking against Hepatitis C (CANUHC) Cohort Investigator Team (2024). Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13995

Vancouver

Imsirovic H, Macphail G, Conway B, Fraser C, Borgia S, Smyth D, et al. Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13995

BibTeX
@article{Imsirovic2024,
  author = {Imsirovic, Haris and Macphail, Gisela and Conway, Brian and Fraser, Chris and Borgia, Sergio and Smyth, Daniel and Wong, Alexander and Vachon, Marie-Louise and Webster, Duncan and Liu, Hongqun and Feld, Jordan and Lee, Sam and Cooper, Curtis and Canadian Network Undertaking against Hepatitis C (CANUHC) Cohort Investigator Team, Canadian Network Undertaking against Hepatitis C (CANUHC) Cohort Investigator Team},
  title = {Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis},
  journal = {Journal of Viral Hepatitis},
  year = {2024},
  doi = {10.1111/jvh.13995}
}
Kostenlos starten →